RA0137

antibody from Oursmab

Targeting: CEACAM5 CD66e, CEA

Western blot (Supportive data in Antibodypedia)

ELISA (Supportive data in Antibodypedia)

Immunocytochemistry (Recommended by provider)

Flow cytometry (Recommended by provider)

Functional assay (Recommended by provider)

Antibody Data

Product number

RA0137

Provider

Oursmab

Product name

Cergutuzumab (Biosimilar Reference Antibody) (CEACAM5)

Antibody type

Monoclonal

Description

Cergutuzumab is an investigational bispecific monoclonal antibody (specifically, a T-cell engager) developed for the treatment of solid tumors. It is designed using a novel CEACAM5-targeting platform to redirect and activate the patient's own T cells specifically against cancer cells expressing a certain tumor-associated antigen. Clinical trials have explored its potential in carcinoembryonic antigen (CEA)-positive advanced or metastatic adenocarcinomas, such as colorectal and lung cancers.

Reactivity

Human

Isotype

IgG

Vial size

100 ¦Ìg,1 mg,5 mg,10 mg,25 mg,50 mg,100 mg

Concentration

Bottled at the concentration indicated on the vial.

Storage

Store at -20¡ãC or -80¡ãC. Avoid repeated freeze.

Western blot

Supportive validation

Submitted by

Oursmab (provider)

Main image

Experimental details

Cergutuzumab (Biosimilar Reference Antibody) (CEACAM5)-RA0137-Oursmab determined by SDS-PAGE. The purity of the protein is greater than 98%.

ELISA

Supportive validation

Submitted by

Oursmab (provider)

Main image

Experimental details

ELISA plate pre-coated Antigen protein, can bind Cergutuzumab (Biosimilar Reference Antibody) (CEACAM5)-RA0137 in a linear range of 3.91-125 ng/mL.